Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Anastomotic Leak × Saline Solution × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 24 Pain, Postoperative 17 Parkinson Disease 4, Autosomal Dominant Lewy Body 12 Neoplasms 12 Lung Neoplasms 11 Brain Neoplasms 9 Ovarian Neoplasms 8 Prostatic Neoplasms 7 Colorectal Neoplasms 7 Depression 6 Colonic Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Carcinoma, Hepatocellular 6 Thyroid Neoplasms 5 Pancreatic Neoplasms 5 Head and Neck Neoplasms 5 Stomach Neoplasms 4 Pain 4 Anxiety Disorders 4 Urinary Bladder Neoplasms 3 Thromboembolism 3 Supratentorial Neoplasms 3 Stomatitis 3 Rectal Neoplasms 3 Neoplasm Metastasis 3 Myofibroma 3 Multiple Myeloma 3 Lymphoma 3 Hemorrhage 3 Fatigue 3

Interventions

Indocyanine Green 2 Ileostomy 2 Water 1 Tobramycin 1 Tissue Adhesives 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Saline Solution 1 Robotic Surgical Procedures 1 Neomycin 1 Metronidazole 1 Methods 1 Levofloxacin 1 Inulin 1 Fibrin Tissue Adhesive 1 Esophagectomy 1 Enoxaparin 1 Endoscopy 1 Enbucrilate 1 Congresses as Topic 1 Colistin 1 Ciprofloxacin 1 Cathartics 1 Bioseal 1 Amphotericin B 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02682485 2023-04-26

SES-DTA

University of Chicago

Phase 2 Withdrawn

Gastrointestinal

Rectal Neoplasms, Anastomotic Leak

Data powered by HemOnc (CC BY 4.0) Colophon ⚡